Discussions during the summit brought forth impactful insights garnered from like-minded, visionaries with a focus on quality and patient outcomes for advancing the world of health
Dialogue 2019 Leadership Summit organised by BD Life Sciences – Pre-analytical Systems in India marked the success of 70 years of BD Vacutainer worldwide. The discussions held in Gurugram had impactful insights garnered from like-minded, visionaries with a focus on quality and patient outcomes for advancing the world of health.
The summit was attended by Dr A Velumani, Founder, CMD, Thyrocare; Om Manchanda, CEO, Dr LalPath Labs; Dr Nandakumar Jairam, CEO, Columbia Asia Hospitals; Dr Vandana Jain, Head, Accreditation of Medical Testing Laboratories; Dr Navin Dang, Founder, Dr Dang Labs; Sanjeev Vashishta, CEO, Pathkind;Dr Shubnum Singh, Director, Max Group of Hospitals and Chairperson, Healthcare Sector Skill Council, Dr Sanjay Arora, Managing Director, Suburban Diagnostics and Girish Mehta, CEO, Eurofins.
A fragmented diagnostic sector in India demands accurate and reliable pathology laboratory results to enable doctors in providing evidence-based patient care and quality treatment. In this pursuit of excellence and quality, all the attendees expressed a well-rounded perspective of offering their best in serving the patients. They also acknowledged that the complicated industry requires strong cohesion between public and private partners to advance the world of health, together.
Speaking about the legacy of BD Vacutainer, Pavan Mocherla, MD, BD–India and South Asia, said, “With our work in market development, innovation and commitment towards advancing healthcare and improving patient outcomes, we aim to maintain the gold standard created by BD Vacutainer. What might appear to be a simple plastic/glass tube, is an epitome of dedicated science, with years of expertise and experience packed into it. However, our work does not end there. Training of healthcare workers to manage sample collection optimally is invaluable for accurate diagnosis and treatment outcomes; hence, BD has been committed to capability building. Looking back at the 70 years of innovation and the road ahead excites me about the opportunity we have to shape the ever-evolving diagnostics industry in India.”